Stocktoria
NOVAVAX INC NVAX
NOVAVAX INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $682.2M | $983.7M | $2.0B | $1.1B | $475.6M | $18.7M | $34.3M | $31.2M | $15.4M |
| R&D expense | $342.3M | $391.2M | $737.5M | $1.2B | $2.5B | $747.0M | $113.8M | $173.8M | $168.4M | $237.9M |
| SG&A expense | $157.5M | $337.2M | $468.9M | $488.7M | — | — | — | — | — | — |
| Operating income | $452.8M | -$248.9M | -$566.5M | -$644.7M | -$1.7B | -$416.7M | -$120.6M | -$173.9M | -$171.7M | -$269.1M |
| Interest expense | — | — | $14.4M | $19.9M | $21.1M | $15.1M | $13.6M | $13.6M | $14.1M | $13.0M |
| Income tax | $1.9M | $10.9M | $2.0M | $4.3M | $29.2M | $0 | $0 | — | — | — |
| Net income | $440.3M | -$187.5M | -$545.1M | -$657.9M | -$1.7B | -$418.3M | -$132.7M | -$184.7M | -$183.8M | -$280.0M |
| EPS (diluted) | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 | $-7.27 | $-5.51 | — | — | — |
| Operating cash flow | -$244.6M | -$87.3M | -$714.0M | -$415.9M | $322.9M | -$42.5M | -$136.6M | -$184.8M | -$144.5M | -$258.8M |
| Cash & equivalents | $240.6M | $530.2M | $568.5M | $1.3B | $1.5B | $553.4M | $78.8M | $70.2M | $106.3M | $144.4M |
| Inventory | $11.5M | $8.7M | $41.7M | $36.7M | $8.9M | — | — | — | — | — |
| Total assets | $1.2B | $1.6B | $1.8B | $2.3B | $2.6B | $1.6B | $173.0M | $208.0M | $302.5M | $394.3M |
| Total liabilities | $1.3B | $2.2B | $2.5B | $2.9B | $2.9B | $955.3M | $359.0M | $375.9M | $404.2M | $399.8M |
| Shareholders' equity | -$127.8M | -$623.8M | -$716.9M | -$634.1M | -$351.7M | $627.2M | -$186.0M | -$167.9M | -$101.7M | -$5.5M |
Growth · year-over-year · Revenue CAGR 61.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +64.7% | -30.7% | -50.4% | +72.9% | +141.0% | +2448.5% | -45.6% | +10.0% | +103.1% | -57.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.